Updated:
ImmunoGen, Inc.
ImmunoGen, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000855654, and its reported industry is...
Overview
ImmunoGen, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000855654, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2023-03-01, it reported annual revenue of USD 108,782,000; net income of USD -222,929,000; total assets of USD 348,936,000 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- ImmunoGen, Inc.
- Former names in filing history
- IMMUNOGEN INC (1994-02-14 to 2019-08-05)
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Waltham, MA, United States
- Incorporated in
- MA
- Fiscal year end
- December 31
- SEC CIK
- 0000855654
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2022USD | $108.8M | -$222.9M | $348.9M | $275.1M | -$229.8M | |
| FY2021USD | $69.9M | -$139.3M | $525.8M | $478.8M | -$169.4M | |
| FY2020USD | $132.3M | -$44.4M | $355.1M | $293.9M | -$78.6M | |
| FY2019USD | $82.3M | -$104.1M | $235.3M | $176.2M | -$88.4M |
FY2019. Net income: shown as originally filed; later filings report different values for the same periods.
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 8-K | FORM 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research ImmunoGen, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.